Advances in prognostic markers for colorectal cancer
L Duan, W Yang, X Wang, W Zhou… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Colorectal cancer (CRC) is one of the most common malignant tumors
worldwide and contributes significantly to cancer-related deaths. Since CRC is largely …
worldwide and contributes significantly to cancer-related deaths. Since CRC is largely …
Epigenetic biomarkers in colorectal cancer
Developments in the diagnosis and treatment of colorectal cancer (CRC) have been made
in the last decade, but the overall survival rate of patients with CRC has not improved …
in the last decade, but the overall survival rate of patients with CRC has not improved …
A 19-Gene expression signature as a predictor of survival in colorectal cancer
NA Abdul Aziz, NM Mokhtar, R Harun… - BMC medical …, 2016 - Springer
Background Histopathological assessment has a low potential to predict clinical outcome in
patients with the same stage of colorectal cancer. More specific and sensitive biomarkers to …
patients with the same stage of colorectal cancer. More specific and sensitive biomarkers to …
Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling
J Martinez-Romero, S Bueno-Fortes, M Martín-Merino… - BMC genomics, 2018 - Springer
Background Identification of biomarkers associated with the prognosis of different cancer
subtypes is critical to achieve better therapeutic assistance. In colorectal cancer (CRC) the …
subtypes is critical to achieve better therapeutic assistance. In colorectal cancer (CRC) the …
[HTML][HTML] A seven-gene signature predicts overall survival of patients with colorectal cancer
Colorectal cancer (CRC) is a major cause of global cancer mortality. Gene expression
profiles can help predict prognosis of patients with CRC. In most of previous studies, disease …
profiles can help predict prognosis of patients with CRC. In most of previous studies, disease …
PHF5A promotes colorectal cancer progression by alternative splicing of TEAD2
Y Chang, Y Zhao, L Wang, M Wu, C He… - … Therapy-Nucleic Acids, 2021 - cell.com
Dysregulated alternative splicing (AS) plays critical roles in driving cancer progression, and
the underlying mechanisms remain largely unknown. Here, we demonstrated that PHF5A, a …
the underlying mechanisms remain largely unknown. Here, we demonstrated that PHF5A, a …
Paeonol exerts anti-tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β-catenin signaling …
LH Liu, RJ Shi, ZC Chen - International Journal of …, 2020 - spandidos-publications.com
Paeonol is a simple phenolic compound isolated from herbal root bark, which has been
reported to possess numerous biological and pharmacological characteristics, including a …
reported to possess numerous biological and pharmacological characteristics, including a …
Cluster analysis on high dimensional RNA-seq data with applications to cancer research-An evaluation study
L Vidman, D Källberg, P Rydén - PLoS One, 2019 - journals.plos.org
Background Clustering of gene expression data is widely used to identify novel subtypes of
cancer. Plenty of clustering approaches have been proposed, but there is a lack of …
cancer. Plenty of clustering approaches have been proposed, but there is a lack of …
The prognostic 97 chemoresponse gene signature in ovarian cancer
Patient diagnosis and care would be significantly improved by understanding the
mechanisms underlying platinum and taxane resistance in ovarian cancer. Here, we aim to …
mechanisms underlying platinum and taxane resistance in ovarian cancer. Here, we aim to …
[HTML][HTML] An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer
Identification of a potential gene signature for improved diagnosis in non-small cell lung
cancer (NSCLC) patient is necessary. Here, we aim to establish and validate the prognostic …
cancer (NSCLC) patient is necessary. Here, we aim to establish and validate the prognostic …